Dollar-Based vs Claim-Count Aberrancy
Short answer
PharmaFix displays two report-based estimates: a paid-dollar rate and a claim-count rate. They can differ because they use different numerators and denominators. Confirm the applicable definitions in current payer documents.
Why the two diverge
A single high-cost aberrant claim can move the dollar test noticeably while adding only one to the claim count. Conversely, many small aberrant claims can lift the count test while barely touching dollars. Looking at one test alone can hide the other.
Which to act on
- If the dollar test is high, a few expensive aberrant claims are likely the driver.
- If the claim-count test is high, aberrant products are appearing frequently.
- If both are climbing, treat it as a clearer signal to review sooner.
Side by side
| Dollar test | Claim-count test | |
|---|---|---|
| Numerator | Aberrant paid dollars | Aberrant claims |
| Denominator | Total paid dollars | Total claims |
| Moved most by | A few high-cost claims | Frequent aberrant fills |
| Typical driver | One expensive product | A routine that repeats daily |
| Blind spot if watched alone | Frequency creep | A single big-ticket claim |
Scope and limitations
This article is general product information, not legal, clinical, contracting, audit, or dispensing advice. PharmaFix uses the supported fields and bundled reference data described in the product; it does not speak for any payer or guarantee that a payer will calculate or act the same way. Review current network documents and obtain professional advice where appropriate.
Same pharmacy, two stories
On $80,000 total paid and 1,000 claims: if aberrant paid is $16,000 across just 12 claims, the dollar estimate is 20% while the count estimate is 1.2%. The example shows why the two metrics cannot be substituted for one another.
Illustrative figures only. Your numbers depend on your own volume and mix.
Common mistakes
- Reporting one test as 'the' aberrancy rate and ignoring the other.
- Assuming a low claim count means a low dollar share.
How PharmaFix helps
PharmaFix tracks both tests together and lets you toggle between them, and it highlights the single high-dollar claim that can move the dollar test on its own, so you see the full picture at a glance.
Frequently asked questions
Which test do networks care about?
Both are commonly discussed. Because they can diverge, monitoring each is the safe approach. PharmaFix shows both.
Estimate your report's position against the 25% reference line
Current checkout is test mode. Upload only an authorized PrimeRx or Caremark report without direct patient identifiers. PharmaFix calculates report-based rates and is designed not to retain report rows or results.